News Focus
News Focus
icon url

DB9

03/10/07 9:07 AM

#3005 RE: keitern #3004

Great News !!!


Phase II
Study of MM-093 to Treat Patients With Patients With Uveitis
This study is currently recruiting patients.
http://clinicaltrials.gov/ct/search;jsessionid=A26D0262BAB2EC25502B78A8E8582735?term=MM-093
Last Updated: March 7, 2007


Not yet on Merrimack Pharma!!
http://www.merrimackpharma.com/pipeline/index.html
icon url

jessellivermore

03/10/07 5:20 PM

#3007 RE: keitern #3004

I appreciate the vote of confidence, but I don't think you are going to need my help or Paris, Sophia or John Bearsford Tipton with this stock. I have been around for a long time and have seen seen some good values. Metreal in the fifties when they came with Metrecal, Nintendo when they were on the overseas board and would close limit up for days. Iomega was under two when they came with their Zipdrive: but I honestly can not remember a better value than this stock.

Throw in the fact you have a guy like Dew who is a thorough as a document shreader sheparding the site. His range of knowledge about the biotechs in general may be as good as anyones. I infer he is fairly enthusiastic about the prosects of GTCB also. This should lend some comfort to those getting tired of the waiting. In the market good waiters get good tips.

Be patient :)